Global Frequency and Diagnosis of Hereditary Angioedema with Normal C1INH: A Real World ACARE Survey

Magerl M

ACARE Global Angioedema Forum 2024 (GAF)

Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks

Zanichelli A

ACARE Global Angioedema Forum 2024 (GAF)

Impact of Delayed Treatment of Hereditary Angioedema Attacks on Quality of Life and Ability to Work

Yong P

ACARE Global Angioedema Forum 2024 (GAF)

Impact of Hereditary Angioedema Attacks on Quality of Life and Ability to Work Among UK Patients Receiving Long-term Prophylaxis or On-demand Treatment Only

Savic S

ACARE Global Angioedema Forum 2024 (GAF)

The Hereditary Angioedema (HAE) Attack Journey: A Conceptual Model of Patient Anxiety and On-Demand Treatment Burden During an HAE Attack

Jones D

ACARE Global Angioedema Forum 2024 (GAF)

Phase 3 KONFIDENT Trial of Oral Sebetralstat for Treatment of Hereditary Angioedema Attacks: Analysis of the European and US Patient Subgroups

Zanichelli A

ACARE Global Angioedema Forum 2024 (GAF)

Impact of Oral Sebetralstat on Anxiety Associated with Hereditary Angioedema Attacks in the Phase 3 KONFIDENT Trial

Maurer M

ACARE Global Angioedema Forum 2024 (GAF)

Patient-Reported Benefits of Early On-demand Treatment of HAE Attacks

Guilarte M

ACARE Global Angioedema Forum 2024 (GAF)

Advent of oral medications for the treatment of hereditary angioedema

Valerieva A, Caballero T, Magerl M, Frade JP, Audhya PK, Craig PK

Clinical and Translational Allergy

KONFIDENT-S Interim Analysis: Sebetralstat for Hereditary Angioedema Attacks (Including Laryngeal)

Farkas H

Bradykinin Symposium 2024